20 May 2025
#fda #covid-19 #vaccine #high-risk populations
The FDA has announced new guidelines to ensure the safety and effectiveness of the COVID-19 vaccine in high-risk populations. This decision aligns with the CDC's recommendation to prioritize these vulnerable groups in the distribution of the vaccine.
30 Jul 2025
#fda #elevidys #voluntary_hold
The FDA has recommended the removal of the voluntary hold for Elevidys, a revolutionary medication for ambulatory patients.
30 Jul 2025
#fda #kratom #public_health #opioids #addiction
The FDA has announced a crackdown on the opioid-like substance kratom, raising concerns about its potential for abuse and addiction. This blog explores the impact of the crackdown and the potential benefits for public health.
02 Aug 2025
The recent FDA panel on the safety of using SSRIs during pregnancy has sparked concern and debate among medical professionals and patients.
11 Aug 2025
Vinay Prasad, top FDA regulator, is reinstated after being ousted due to political tension and the need for regulatory independence.